European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Tenders

Antibiotics tenders in Czechia

Antibiotics tenders in Czechia: 539 listed on GranTender since 2024; 3 open now. The median awarded contract value is about €69,000 (407 contracts with a stated value). Buyers with the most tenders: Fakultní nemocnice Olomouc (72), Krajská zdravotní, a.s. (62) and Krajská nemocnice T. Bati, a. s. (52); suppliers with the most contract awards: Gilead Sciences s.r.o. (65), ViaPharma s.r.o. (61) and Merck Sharp & Dohme s.r.o. (32). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €92,000; 44% of contracts drew a single bid (3.2 bids on average). Data as of 17 November 2026; updated daily.

Tenders
539
Open tenders
3
Awards
1,064
Awarded value awarded
€96,197,250
Awarded value contract
€81,690,995
Awarded value framework ceiling
€68,577,245
Median contract value awarded
≈ €69,000
Median contract value contract
≈ €73,000
Median contract value framework ceiling
≈ €87,000
Average bids per contract
2.9
Tenders in 2025
168 -32% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
LP s obsahem glekapeviru a pibrentasviru 2026 - sdružený nákupFakultní nemocnice OlomoucCZK 64,934,100 (≈ €2,672,625)Open16 November 2026
Perorální antivirotikum s kombinací účinných látek Darunavirum a CobicistatumFakultní nemocnice OstravaCZK 3,949,472 (≈ €162,556)Open13 November 2026
dodatek č.1 - Antibiotika – veřejná lékárna“ část 1Fakultní nemocnice Hradec Králové—Awarded2 November 2026
Laboratorní technologie pro identifikaci mikroorganismů a stanovení citlivosti k antibiotikůmFakultní nemocnice Brno—Open26 October 2026
LP s obsahem molnupiraviru 2026 - sdružený nákupFakultní nemocnice OlomoucCZK 7,561,996 (≈ €311,244)Closed25 September 2026
LP s obsahem ceftazidimu 2026Fakultní nemocnice OlomoucCZK 3,710,269 (≈ €152,711)Closed26 August 2026
Antivirotika pro systémové použití – CMV – Letermovir, Maribavir II.Institut klinické a experimentální medicínyCZK 18,900,000 (≈ €777,906)Awarded20 August 2026
Antibakteriální látky pro systémové použití XL. - FidaxomicinInstitut klinické a experimentální medicínyCZK 8,900,000 (≈ €366,315)Awarded12 August 2026
Sofosbuvir a velpatasvirÚstřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 21,829,300 (≈ €898,473)Closed4 August 2026
Sofosbuvir a velpatasvirÚstřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 21,829,300 (≈ €898,473)Closed4 August 2026
Sofosbuvir a velpatasvirÚstřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 21,829,300 (≈ €898,473)Closed3 August 2026
LP s obsahem letermoviru 2026Fakultní nemocnice OlomoucCZK 14,379,219 (≈ €591,835)Awarded29 July 2026
Dodávky ZP IVD – Diagnostické soupravy pro genetický průkaz respiračních virových a bakteriálních patogenů z dolních cest dýchacích (sputum, BAL, aspirát z dýchacích cest) vč. genů rezistence na antibiotikaFakultní Thomayerova nemocnice—Closed17 July 2026
Antibakteriální látky pro systémové použití XXXIX. – Clindamycin, Colistin, LinezolidInstitut klinické a experimentální medicínyCZK 3,230,000 (≈ €132,944)Awarded8 July 2026
LP s obsahem foskarnetu II. 2026Fakultní nemocnice OlomoucCZK 7,409,472 (≈ €304,967)Awarded3 July 2026
LP s obsahem klindamycinu i.v. 2026Fakultní nemocnice Olomouc—Cancelled30 June 2026
Léčivé přípravky s obsahem kolistinuFakultní nemocnice Hradec KrálovéCZK 10,980,000 (≈ €451,926)Awarded22 June 2026
Léčivé přípravky s obsahem kolistinuFakultní nemocnice Hradec KrálovéCZK 10,980,000 (≈ €451,926)Closed22 June 2026
Léčivé přípravky s obsahem kolistinuFakultní nemocnice Hradec Králové—Awarded19 June 2026
DNS Výzva č. 101 J01CF04 - OXACILINMěstská nemocnice Ostrava, příspěvková organizace—Awarded16 June 2026

Competition and prices

In 2025, half of the contracts were worth between €29,000 and €240,000, with a median of €92,000 (134 contracts with a stated awarded value). Contracts drew 3.2 bids on average (median 2) and 44% drew a single bid — based on 321 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 88% and the share of single-bid contracts rose from 39% to 44%. The usual procedures: open procedure (82%), other procedures (17%), direct award (1%) — of 374 tenders with a stated procedure.

The most contracts went to Gilead Sciences s.r.o. (65), ViaPharma s.r.o. (61) and Merck Sharp & Dohme s.r.o. (32) — together 15% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024424€49,000€15,000 – €150,0003.239% (241)
2025372€92,000€29,000 – €240,0003.244% (321)
2026 (so far)225€120,000 (contract value)€41,000 – €370,0002.342% (200)
All years1,063€69,000€22,000 – €220,0002.943% (783)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 42% of the 565 contracts with a known number of bids had a single bid; the median was 2 bids. The number of bids is known for 565 of the 648 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 82 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33651000 General anti-infectives for systemic use and vaccines

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Antibiotics and anti-infectives in neighbouring countries

Today, 11 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon3

ExpectedBuyerWhatWhy we expect itConfidence
now – Nov 2026
every year
Fakultní Thomayerova nemocniceAntibiotics and anti-infectives
Dodávky léků – Léčivá látka nirmatrelvir a ritonavir – ATC J05AE30
Typical value: ≈ €770,000
The buyer has published antibiotics tenders every year in November since 2024.
Earlier tenders: 11/2025, 11/2024
medium
now – Nov 2026
every year
Krajská nemocnice Liberec, a.s.Antibiotics and anti-infectives
Léčivé přípravky s obsahem účinné látky sodná sůl ampicilinu
Typical value: ≈ €160,000
The buyer has published antibiotics tenders every year in November since 2024.
Earlier tenders: 11/2025, 11/2024
medium
now – Apr 2027
contract ends
Zdravotnické zařízení Ministerstva vnitraAntibiotics and anti-infectives
Průběžné nákupy vakcín pro Zdravotnické zařízení Ministerstva vnitra
Typical value: ≈ €2.1m
The current contract with Avenier a.s. ends on 5 May 2027; no new tender has been published yet.
Earlier tenders: 02/2024
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Antibiotics and anti-infectives by city

Antibiotics and anti-infectives in other countries

Antibiotics and anti-infectives across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which antibiotics tenders in Czechia are open now?
3 of the 539 antibiotics tenders in Czechia listed on GranTender are open for bids. For example: LP s obsahem glekapeviru a pibrentasviru 2026 - sdružený nákup; Perorální antivirotikum s kombinací účinných látek Darunavirum a Cobicistatum; Laboratorní technologie pro identifikaci mikroorganismů a stanovení citlivosti k antibiotikům.
Where can I find antibiotics tenders in Czechia?
GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values; 3 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most antibiotics tenders in Czechia?
By number of contracts won: Gilead Sciences s.r.o. (65), ViaPharma s.r.o. (61), Merck Sharp & Dohme s.r.o. (32).
Which buyers publish the most antibiotics tenders in Czechia?
By number of tenders: Fakultní nemocnice Olomouc (72), Krajská zdravotní, a.s. (62), Krajská nemocnice T. Bati, a. s. (52).
Which CPV codes belong to “Antibiotics and anti-infectives”?
33651000 General anti-infectives for systemic use and vaccines; plus tenders without a usable CPV code whose title names the topic.
How many bids do antibiotics tenders in Czechia receive on average?
In 2025, contracts drew 3.2 bids on average (median 2) and 44% drew a single bid — based on 321 contracts with a known number of bids.
How much are contracts for antibiotics tenders in Czechia worth?
In 2025, half of the contracts were worth between €29,000 and €240,000, with a median of €92,000 (134 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 88% and the share of single-bid contracts rose from 39% to 44%.
Which procedures are used for antibiotics tenders in Czechia?
The usual procedures: open procedure (82%), other procedures (17%), direct award (1%) — of 374 tenders with a stated procedure.
Which buyers get few offers in antibiotics tenders in Czechia?
Since 1 November 2024, these buyers usually received one or two offers per contract: Fakultní nemocnice Olomouc (median 2 bids over 115 contracts), Městská nemocnice Ostrava, příspěvková organizace (median 2 bids over 50 contracts) and Fakultní nemocnice Ostrava (median 1 bid over 22 contracts). Since 1 November 2024, 42% of the 565 contracts with a known number of bids had a single bid; the median was 2 bids.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.